The companies agreed to team up to develop and manufacture new fractional flow reserve wires that handle better than existing products. The devices will be designed to work with Boston Scientific’s Polaris multi-modality imaging technology, according to a press release.
The duo will also pursue improvements to Boston Scientific’s RotaWire atherectomy guidewires, with Asahi slated to provide components that will improve control and handling.
"We expect our collaboration with Asahi Intecc to help improve care for patients with coronary artery disease and strengthen our interventional cardiology portfolio," Boston Scientific interventional cardiology president Kevin Ballinger said in prepared remarks. "The Asahi Intecc expertise in guidewire technology is unparalleled. By leveraging the strengths of our technologies, we have the opportunity to create truly differentiated products."
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.